Skip to main content

REVIEW article

Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1493511
This article is part of the Research Topic Outbreak Investigations of Nosocomial Infections View all 7 articles

Utility of syndromic surveillance for the surveillance of Healthcare-associated Infections in resource-limited settings: A narrative review

Provisionally accepted
Herman Mwanja Herman Mwanja 1*JP Waswa JP Waswa 2Reuben Kiggundu Reuben Kiggundu 1Hope Mackline Hope Mackline 1Daniel Bulwadda Daniel Bulwadda 3,4Dathan M. Byonanebye Dathan M. Byonanebye 1,3,5Andrew Kambugu Andrew Kambugu 1Francis Kakooza Francis Kakooza 1,3
  • 1 Centres for Antimicrobial Optimization Network (CAMO-Net), Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
  • 2 Management Sciences for Health, Kampala, Uganda
  • 3 Global Health Security Department, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
  • 4 Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
  • 5 School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda

The final, formatted version of the article will be published soon.

    Globally, Healthcare-associated infections (HCAIs) pose a significant threat to patient safety and healthcare systems. In low-and middle-income countries (LMICs), the lack of adequate resources to manage HCAIs, as well as the weak healthcare system, further exacerbate the burden of these infections. Traditional surveillance methods that rely on laboratory tests are cost-intensive and impractical in these settings, leading to ineffective monitoring and delayed management of HCAIs.The rates of HCAIs in resource-limited settings have not been well established for most LMICs, despite their negative consequences. This is partly due to costs associated with surveillance systems. Syndromic surveillance, a part of active surveillance, focuses on clinical observations and symptoms rather than laboratory confirmation for HCAI detection. Its cost-effectiveness and efficiency make it a beneficial approach for monitoring HCAIs in LMICs. It provides for early warning capabilities, enabling timely identification and response to potential HCAI outbreaks. Syndromic surveillance is highly sensitive and this helps balance the challenge of low sensitivity of laboratory-based surveillance systems. If syndromic surveillance is used hand-in-hand with laboratory-based surveillance systems, it will greatly contribute to establishing the true burden of HAIs in resource-limited settings.Additionally, its flexibility allows for adaptation to different healthcare settings and integration into existing health information systems, facilitating data-driven decision-making and resource allocation. Such a system would augment the event-based surveillance system that is based on alerts and rumours for early detection of events of outbreak potential.If well streamlined and targeted, to monitor priority HCAIs such as surgical site infections, hospital-acquired pneumonia, diarrheal illnesses, the cost and burden of the effects from these infections could be reduced. This approach would offer early detection capabilities and could be expanded into nationwide HCAI surveillance networks with standardised data collection, healthcare worker training, real-time reporting mechanisms, stakeholder collaboration, and continuous monitoring and evaluation. Syndromic surveillance offers a promising strategy for combating HCAIs in LMICs. It provides early warning capabilities, conserves resources, and enhances patient safety. Effective implementation depends on strategic interventions, stakeholder collaboration, and ongoing monitoring and evaluation to ensure sustained effectiveness in HCAI detection and response.

    Keywords: Healthcare-associated infections (HCAIs), Syndromic surveillance, resource-limited settings, emergency department, Public health surveillance Formatted: Numbering: Continuous Formatted: Space Before: 0 pt

    Received: 09 Sep 2024; Accepted: 07 Oct 2024.

    Copyright: © 2024 Mwanja, Waswa, Kiggundu, Mackline, Bulwadda, Byonanebye, Kambugu and Kakooza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Herman Mwanja, Centres for Antimicrobial Optimization Network (CAMO-Net), Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.